Preceptorship in Multiple Sclerosis, 21st Ed (2023)
With new insights into the pathogenesis of demyelinating diseases, the development of innovative tools to improve diagnosis and a greater availability of new treatment methods in clinical practice, neurologists specializing in multiple sclerosis are compelled to stay up to date with all the latest developments and ideas about best practices.
Objetivos generales
This course given by specialists in multiple sclerosis provides the opportunity to share their knowledge and help fellow neurologists understand the most recent research in diagnosis, treatment, patient management and rehabilitation with top MS faculty members. This will enable neurologists to be better equipped to adapt and optimize their daily practices according to the needs of their patients.
This course has been granted 10 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Sesión
DAY 1
01
DAY 1
| Programa | MSP21 |
|---|---|
| Día / Hora | 23/11/2023 | 09:30 H - 16:00 H |
| Ponencias |
Welcome to the Multiple Sclerosis Preceptorship & Welcome to Cemcat Ponente: Xavier Montalban
Epidemiology of Multiple Sclerosis Ponente: Susana Otero
Immunopathogenesis of Multiple Sclerosis Ponente: Heinz Wiendl
Genetics of Multiple Sclerosis Ponente: Manuel Comabella
Hystopathology of Multiple Sclerosis Ponente: Tanja Kuhlmann
Clinical Diagnosis of Multiple Sclerosis: criteria and beyond Ponente: Mar Tintoré
Differential Diagnosis of Multiple Sclerosis Ponente: Georgina Arrambide
Value of optic nerve study in Multiple Sclerosis diagnosis Ponente: Ángela Vidal
Artificial Intelligence in Multiple Sclerosis Ponente: Carmen Tur
Clinical Cases Discussion 1 Ponente: Agustín Papolla
Cognitive Impairment of Multiple Sclerosis Ponente: Maria Pia Amato
Visit to the Centre Moderada por: Xavier Montalban |
Sesión
DAY 2
02
DAY 2
| Programa | MSP21 |
|---|---|
| Día / Hora | 24/11/2023 | 09:30 H - 15:50 H |
| Ponencias |
Neuromyelitis optica Ponente: Friedemann Paul
Myelin oligodendrocite glypoprotein antibody Ponente: Romain Marignier
Pediatric and juvenile Multiple Sclerosis Ponente: Yael Hacohen
Imaging in Multiple Sclerosis Ponente: Àlex Rovira
Biomarkers in Multiple Sclerosis Ponente: Jens Kuhle
Overview of treatments and treatment algorithms Ponente: Xavier Montalban
Future treatments: BTKi Ponente: Xavier Montalban
Progressive Multiple Sclerosis Ponente: Alan Thompson
Safety of DMD’s Ponente: Gavin Giovannoni
Brain & spinal cord reserve in Multiple Sclerosis Ponente: Jaume Sastre-Garriga
Clinical cases Discussion 2 Ponente: Andreu Vilaseca Moderada por: Xavier Montalban |